The Department of Health and Human Services will create a Foundry for American Biotechnology to produce technological solutions to address health security threats and enhance daily medical care, the agency announced today. The foundry will be located in Manchester, N.H., and managed in conjunction with the Advanced Regenerative Manufacturing Institute led by DEKA Research Corp., as part of a public-private partnership with HHS’ Office of the Assistant Secretary for Preparedness and Response. Its first project, a partnership with the Defense Advanced Research Projects Agency, will focus on maturing and validating small, automated devices that could go to disaster locations to make necessary medicines on site.

Related News Articles

Headline
The FBI’s Internet Criminal Complaint Center May 15 released an alert warning of a malicious text and voice messaging campaign involving impersonators…
Headline
In his latest AHA Cyber Intel blog, John Riggi, AHA national advisor for cybersecurity and risk, examines the state of cyber and physical threats in 2025 as…
Headline
Health care had more cyberthreats last year than any other critical infrastructure industry, according to the FBI's 2024 Internet Crime Report released April…
Headline
The National Security Agency April 23 released a report on operational technology systems that includes recommendations for security policies and technical…
Chairperson's File
Public
Cybersecurity and physical threats are unfortunately significant enterprise risks for health care, regardless of size or location. Every hospital, physician…
Headline
The Cybersecurity and Infrastructure Security Agency April 17 released guidance to reduce risks associated with a reported breach of Oracle cloud services.…